Loading resource…

Oncology
This manual, in its second edition, provides detailed information on cancer treatment. It covers empirical antibiotic therapy for febrile neutropenia, emphasizing the choice of regimens based on patient risk factors and local pathogen prevalence. The text also delves into the management of diffuse large B-cell lymphoma (DLBCL), discussing the standard R-CHOP chemotherapy regimen and the implications of genetic markers like MYC and BCL-2 translocations. It highlights the evolving landscape of DLBCL treatment, including the role of rituximab and the challenges posed by 'double hit' lymphomas.
No account needed